Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

AM-0715

Known as: AM 0715, AM 715, AM0715 
 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Norfloxacin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
In vitro activity of norfloxacin in urine compared to that of cinnoxacin, nalidixic acid and pipemidic acid
1. Ito, A., Hirai, K., Inoue, M., Koga, H., Suzue, S., Irikura, T., Mitsuhashi, S.: In vitro antibacterial activity of AM-715, a… Expand
  • table 1
  • table 1
  • table 2
1990
1990
[Evaluation of norfloxacin in the pediatric field. Pediatric Study Group for Norfloxacin].
Norfloxacin (NFLX, AM-715), a new quinolone antibiotic agent, was evaluated clinically and bacteriologically for its efficacy and… Expand
Highly Cited
1983
Highly Cited
1983
Mechanism of renal excretion of AM-715, a new quinolonecarboxylic acid derivative, in rabbits, dogs, and humans.
The mechanisms of the renal excretion of AM-715, a synthetic antimicrobial agent, were studied in rabbits, dogs, and humans. In… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Highly Cited
1983
Highly Cited
1983
In vitro antibacterial activity of norfloxacin (MK-0366, AM-715) and other agents against gastrointestinal tract pathogens.
A comparison was made of the in vitro activities of norfloxacin and of nine other orally administered antibacterial agents… Expand
  • table 1
1983
1983
Tentative interpretive standards for disk diffusion susceptibility testing with norfloxacin (MK-0366, AM-715).
Norfloxacin is a new orally absorbed quinoline derivative structurally related to nalidixic acid but showing an expanded… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
  • table 4
1983
1983
Norfloxacin (MK-0366, AM-715): in vitro activity and cross-resistance with other organic acids including quality control limits for disk diffusion testing.
  • R. Jones, A. Barry
  • Diagnostic microbiology and infectious disease
  • 1983
    • Corpus ID: 30310049
Norfloxacin is a new organic acid antimicrobic with an expanded spectrum that includes Staphylococcus spp, most Pseudomonas spp… Expand
1982
1982
[Pharmaceutical studies on hydrates of AM-715. Physical characteristics and intestinal absorption].
 
1981
1981
Comparative in vitro activity of Mk-0366 and other selected oral antimicrobial agents against Neisseria gonorrhoeae.
The in vitro activity of a new ora antimicrobial agent, Mk-0366 (AM-715), was compared with those of rosoxacin, ampicillin… Expand
  • table 1
  • table 2
1981
1981
Comparative Activities of AM-715 and Pipemidic and Nalidixic Acids Against Experimentally Induced Systemic and Urinary Tract Infections
Dose for dose, AM-715 was at least five times as active as pipemidic acid and nalidixic acid against systemic and urinary bladder… Expand
  • table 1
  • table 2
Highly Cited
1980
Highly Cited
1980
In Vitro Antibacterial Activity of AM-715, a New Nalidixic Acid Analog
AM-715 [1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid] is a new nalidixic acid analog. AM-715… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE